Exclude Patient Type Detail Header
No
Detail Type
Text
Detail Text
Patient Type Detail Header (Long)
To prevent RSV-associated LRTI in infants, either RSVpreF vaccination in pregnant parents at 32-36 wk gestation <b>OR</b> nirsevimab immunization in infants <8 mo born during or entering their 1st RSV season is recommended. Administration of both products isn’t needed in most cases.